In HCC, METTL3 enhanced the stability of lncRNA NIFK-AS1 mRNA by increasing the methylation modification level of NIFK−AS1, resulting in increased expression of NIFK-AS1. Here, METTL3 is linked to hepatocellular carcinoma.